New advances in peptide receptor radionuclide therapy.
de Jong
Marion
M
Department of Nuclear Medicine, Erasmus University Medical Center Rotterdam Rotterdam, The Netherlands. dejong@nuge.azr.nl
Krenning
Eric
E
D006801:Humans; D007668:Kidney / Q000528:radiation effects; D018358:Neuroendocrine Tumors / Q000532:radiotherapy*; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D019275:Radiopharmaceuticals / Q000627:therapeutic use*; D015021:Yttrium Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use*
D019275:Radiopharmaceuticals; D015021:Yttrium Radioisotopes; D015282:Octreotide; C106246:Edotreotide